课题基金 / 基金详情

Toward the cure of neuroblastoma: innovative immunotherapeutic approaches

Toward the cure of neuroblastoma: innovative immunotherapeutic approaches
治愈神经母细胞瘤：创新的免疫治疗方法
批准号：
322744
负责人：
Duval Michel
金额：
$72.63万
依托单位：
Centre hospitalier universitaire Sainte-Justine (Montral, Qubec)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2015
资助国家：
加拿大
项目状态：
已结题
起止时间：
2015-03-01 至 2020-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=322744&lang=en
关键词：
Cord Blood Transplantation Dendritic Cells Epigenetic Therapy Immunological Checkpoint Blockade Immunotherapy Mouse Model Of Cord Blood Transplantation Mouse Model Of Human Neuroblastoma Xenograft Natural Killer Cells Relasped/Refractory Neuroblas

项目摘要

项目成果

Duval Michel的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Neuroblastoma is the second most frequent solid tumor in children after cerebral tumors. Most of children with neuroblastoma between 1 and 5 years old present an aggressive disease for which the current therapy includes aggressive chemotherapy, radiothera
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Phase I first-in-human trial for ThINKK adoptive immunotherapy in children with high-risk cancers
Phase I first-in-human trial of ThINKK adoptive immunotherapy in children with high-risk cancers
Adoptive transfers of in vitro differentiated plasmacytoid dendritic cells to prevent acute lymphoblastic leukemia relapse: mechanisms and biomarkers of sensitivity
Preclinical models of natural killer cell-based immunotherapy to cure refractory childhood acute lymphoblastic leukemia
国内基金
海外基金
树突状细胞(Dendritic cells,DCs)介导的黏膜免疫对猪轮状病毒(PRV)感染的分子作用机制研究
  • 批准号：
    31272541
  • 项目类别：
    面上项目
  • 资助金额：
    82.0万元
  • 批准年份：
    2012
  • 负责人：
    王春凤
  • 依托单位：
    吉林农业大学